Andrea Casadei-Gardini

Has grant

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

YOUNG INVESTIGATORS’ REGISTRATION BURSARY - 2016

Open Date:

Close Date:

Grant: Close

OUNG INVESTIGATORS’ REGISTRATION BURSARY - AISF 2015

Open Date:

Close Date:

Articles (11)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (7)

Luca Miele

Catholic University of the Sacred Heart

ITALY

View details

Neehar D. Parikh

University of Michigan

UNITED STATES

View details

Margherita Rimini

ITALY

View details

Prasun K. Jalal

UNITED STATES

View details

Giovanni Galati

Campus Bio Medico University Hospital

ITALY

View details

Paolo Giorgio Arcidiacono

Professore Associato. Direttore UOC Endoscopia BilioPancreatica ed Ecoendoscopia

Università Cattolica del Sacro Cuore Facoltà di Medicina e Chirurgia

ITALY

View details

Lorenza Rimassa

Humanitas University

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Andrea Casadei-Gardini

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (11)

EUS-guided gastroenterostomy for management of malignant gastric outlet obstruction: a prospective cohort study with matched comparison with enteral stenting

Liver resection for HCC in patients with metabolic syndrome: questions answered, questions raised

Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real-world data.

Past, present, and future of FGFR inhibitors in cholangiocarcinoma: from biological mechanisms to clinical applications

Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept.

Regional differences in clinical presentation and prognosis of patients with post-sustained virologic response (SVR) hepatocellular carcinoma.

Updated survival outcomes with ivosidenib in patients with previously treated IDH1-mutated intrahepatic-cholangiocarcinoma: an Italian real-world experience.

Radial and longitudinal margins in surgery of perihilar cholangiocarcinoma: When R1 definition is associated with different prognosis.

Sequential therapies after atezolizumab plus bevacizumab or lenvatinib first-line treatments in hepatocellular carcinoma patients.

Mismatch repair deficiency as prognostic factor for stage III small bowel adenocarcinoma: A multicentric international study.

Identification of Atezolizumab Plus Bevacizumab Prognostic Index <i>via</i> Recursive Partitioning Analysis in HCC: The ABE Index.

Collaborators (7)

Luca Miele

Neehar D. Parikh

Margherita Rimini

Prasun K. Jalal

Giovanni Galati

Paolo Giorgio Arcidiacono

Lorenza Rimassa

Make your next move.